Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC), as one of the common malignant tumors, seriously threatens human health. NEK6 (Never in Mitosis A (NIMA) related kinases 6), as a cyclin, promotes cancer cell proliferation and cancer progression. However, the prognostic value of NEK6 and its correlatio...

Full description

Bibliographic Details
Main Authors:	Zhi-Min Yang, Bing Liao, Si-Si Yang, Tong Su, Jing Zhang, Wei-Ming Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Endocrinology
Subjects:	NEK6 prognosis immune infiltration HNSCC immune checkpoints
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.943686/full

Similar Items

CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma
by: Ying Yang, et al.
Published: (2023-10-01)

Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study
by: Lei Zhang, et al.
Published: (2024-03-01)

NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration
by: Guangxu Xuan, et al.
Published: (2022-06-01)

TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
by: Yaodong He, et al.
Published: (2022-12-01)

The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration
by: Qingjuan Chen, et al.
Published: (2024-03-01)

Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development
by: Dibyendu Dana, et al.
Published: (2022-01-01)

Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration
by: Jianfei Tang, et al.
Published: (2022-07-01)

Nek family of kinases in cell cycle, checkpoint control and cancer
by: Moniz Larissa, et al.
Published: (2011-10-01)

A novel immune-related prognostic model with surgical status to predict tumor immune cell infiltration and drug sensitivity in head and neck squamous cell carcinoma
by: Lang Wang, et al.
Published: (2023-12-01)

Checking NEKs: Overcoming a Bottleneck in Human Diseases
by: Andressa Peres de Oliveira, et al.
Published: (2020-04-01)

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer
by: Wen-Liang Gao, et al.
Published: (2022-03-01)

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma
by: Bangrong Cao, et al.
Published: (2018-02-01)

Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma
by: Huan Li, et al.
Published: (2022-08-01)

Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck
by: Chunyan Li, et al.
Published: (2021-09-01)

Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma
by: Lilan Yi, et al.
Published: (2020-09-01)

The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
by: Marcos Paulo S. Damasio, et al.
Published: (2022-10-01)

Potential Therapeutic Uses of NEK2 in Cancers
by: CHEN Chenglong, et al.
Published: (2018-01-01)

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials
by: Bharat Goel, et al.
Published: (2022-07-01)

Experiment on Inhibiting NEK7 to Promote Apoptosis of Hepatocellular Carcinoma Cells
by: SONG Yanzhou, et al.
Published: (2021-10-01)

NEK8 regulates colorectal cancer progression via phosphorylating MYC
by: Beibei Cao, et al.
Published: (2023-08-01)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
by: Florencia Veigas, et al.
Published: (2021-03-01)

Identification of biological pathways and processes regulated by NEK5 in breast epithelial cells via an integrated proteomic approach
by: Camila de Castro Ferezin, et al.
Published: (2022-12-01)

The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study
by: YuSheng Cheng, et al.
Published: (2018-12-01)

Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
by: Gangga Anuraga, et al.
Published: (2021-10-01)

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
by: Kimberly M. Burcher, et al.
Published: (2021-11-01)

A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
by: Ying-Shi Yuan, et al.
Published: (2022-10-01)

Physiological and Pathological Roles of Mammalian NEK7
by: Zhenzhen Sun, et al.
Published: (2020-12-01)

Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma
by: Wanzun Lin, et al.
Published: (2021-10-01)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
by: Dan Liu, et al.
Published: (2023-01-01)

Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer
by: Qiuli Chen, et al.
Published: (2021-10-01)

Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells
by: Sebastian Wimmer, et al.
Published: (2021-08-01)

Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response
by: Anne-Sophie Becker, et al.
Published: (2023-11-01)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
by: Xueying Wang, et al.
Published: (2021-04-01)

Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma
by: Fujun Zhang, et al.
Published: (2020-10-01)

T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma
by: Daniele Maggioni, et al.
Published: (2017-07-01)

Expression of NEK2 in Colorectal Cancer Tissue and Its Effect on Proliferation, Invasion and Migration of HCT116 Cells
by: CUI Facai, et al.
Published: (2021-02-01)

OGT-induced O-GlcNAcylation of NEK7 protein aggravates osteoarthritis progression by enhancing NEK7/NLRP3 axis
by: Chunlei He, et al.
Published: (2024-12-01)

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
by: Renheng Zou, et al.
Published: (2023-05-01)

COL3A1: Potential prognostic predictor for head and neck cancer based on immune‐microenvironment alternative splicing
by: Yuchen Shen, et al.
Published: (2023-02-01)

NEK5 interacts with LonP1 and its kinase activity is essential for the regulation of mitochondrial functions and mtDNA maintenance
by: Camila de Castro Ferezin, et al.
Published: (2021-03-01)